NEW YORK (Reuters Health) – Prompt treatment of subclinical and clinical seizures in newborns with hypoxic-ischemic encephalopathy (HIE) can potentially decrease brain injury, according to a prospective trial…
NEW YORK (Reuters Health) – High-dose atorvastatin does not protect against contrast-induced nephropathy (CIN) in patients with kidney disease, Italian researchers report. “Statins have recently been proposed for…
NEW YORK (Reuters Health) – The biomarker procalcitonin can help guide treatment of severe bacterial infections in the intensive care unit (ICU), French investigators report online in The…
NEW YORK (Reuters Health) – Endovascular treatment of intracranial aneurysms 3 mm or smaller in diameter is difficult and risky — but it’s successful in over 90% of…
NEW YORK (Reuters Health) – Giving beta-blockers within 8 hours of presentation with acute coronary syndrome (ACS) does not reduce in-hospital mortality, a meta-analysis has shown. Beta-blockers reduce…
NEW YORK (Reuters Health) – Thiazolidinediones (TZDs) are linked to an increased risk for extremity fractures in women over age 65, findings from a large retrospective cohort study…
NEW YORK (Reuters Health) – In patients with coronary shock and multivessel coronary disease, 30-day and 1-year mortality rates appear to be similar after percutaneous coronary intervention (PCI)…
NEW YORK (Reuters Health) – Cladribine and fingolimod, the first oral agents for multiple sclerosis (MS), significantly reduce relapse rates, risks of disability progression, and disease activity, according…
NEW YORK (Reuters Health) – In patients with poor-grade subarachnoid hemorrhage, hypertonic saline improves cerebral blood flow and enhances cerebral tissue oxygenation for 4 hours post-infusion, UK researchers…
NEW YORK (Reuters Health) – In an update to their 2005 recommendation, the US Preventive Services Task Force now recommends that clinicians screen children and adolescents ages 6…
NEW YORK (Reuters Health) – When it comes to preventing atrial fibrillation, not all antihypertensive agents are created equal. New research suggests that angiotensin-converting enzyme (ACE) inhibitors, angiotensin…
NEW YORK (Reuters Health) – Repeat cardiac catheterizations and use of vascular closure devices do not reduce femoral artery size at the puncture site or promote progression of…
